By Duncan Bridgeman
Friday 16th July 2004 |
Text too small? |
Blue Chip, which last month gained a backdoor listing on the NZX through former IT company Newcall, this week turned in a consolidated June-half net profit of $1.89 million.
Blue Chip's 52.5 million shares, of which Bryers owns 75.4%, last traded at $1.25.
According to NZX data the company carries an earnings multiple of 14.7.
The company is set to raise further capital through a pro-rata rights issue to help fund what chief executive Nick Wevers' describes as "substantial" expansion plans.
Wevers said the upcoming rights issue was also designed to give Newcall shareholders the chance to subscribe to a meaningful parcel after they ended up with just 2.5 million shares following the consolidation.
"We won't disclose exactly what our plans are at this stage but it won't be too far away," he said.
It was likely the company would be looking to expand further into financial services.
The rights issue was expected to be at a discount to the prevailing market price, he said.
Blue Chip's result included the performance of Newcall, which recorded a loss of $176,000 over the period.
Wevers said the company looked to be on target for a full-year after-tax profit of about $8 million, or 15c a share.
That compared with a net profit of just over $5 million last year, he said.
Founded by Bryers and former bankrupt Bob Bangerter, Blue Chip aims to encourage residential investors to use the equity in their homes to fund themselves into other properties.
The company runs seminars, gets tenants for investors and manages a housing portfolio.
In 2001, two of Bryers' property companies were put into liquidation.
No comments yet
NZK FY25 Results Announcement details
PEB - Cxbladder Incorporated into AUA Clinical Guideline
SUM - Financial Results for the Year Ended 31 December 2024
SUM - Sustainability Review & Climate-Related Disclosures FY24
MOVE Appoints Paul Millward as CEO
Port of Tauranga reports FY25 interim results
ENS - Half Year Report to 31 December 2024
TruScreen Signs MOU with Hangzhou Dalton Bioscience
February 27th Morning Report
GTK - ASM Chair's address and Presentation